Rational application of EGFR-TKI adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant NSCLC: A systematic review and meta-analysis of 11 randomized controlled trials

Định dạng: PDF / Số trang: 14

Nhắn tin với admin nếu không tải được